Published in Medical Letter on the CDC and FDA, November 22nd, 2009
Quality assurance and regulatory experts from the Food and Drug Administration's Center for Drug Evaluation and Research (FDA/CDER) and GlaxoSmithKline (GSK) will be on hand for a discussion on the challenges and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.